Skip to main content

Table 1 Characteristics of patients involved in the study

From: BRAFV600E mutation impinges on gut microbial markers defining novel biomarkers for serrated colorectal cancer effective therapies

Sample name

Age

Sex

Location of cancer

AJCC Stage

BRAFV600E

MI4KC

63

M

Left colon

IIIA

wild type

MI6KC

62

M

Rectum

IIIB

wild type

MI7KC

73

M

Right colon

IIA

wild ttype

MI11KC

50

M

Rectum

IV

wild type

MI12KC

74

F

Left colon

IIIA

wild type

MI15KC

74

M

Right colon

IV

mutated

MI16KC

49

M

Rectum

IV

mutated

MI17KC

49

F

Left colon

IIA

wild type

MI23KC

53

F

Right colon

IV

mutated

MI22KC

67

M

Rectum

IV

mutated

MI27KC

80

F

Right colon

IIIA

wild type

MI31KC

81

M

Rectum

IIIB

wild type

MI32KC

80

M

Right colon

II

wild type

MI34KC

80

M

Right colon

IIA

mutated

MI36KC

51

F

Rectum

IIA

wild type

MI39KC

49

M

Rectum

IV

wild type

MI41KC

77

M

Right colon

IV

mutated

MI40KC

55

M

Left colon

IV

mutated

MI9KC

76

M

Rectum

I

wild type

MI10KC

87

F

Left colon

I

wild type

MI19KC

68

M

Right colon

I

wild type

MI20KC

85

F

Right colon

I

wild type

MI21KC

87

F

Left colon

I

wild type

MI25KC

70

M

Left colon

I

wild type

MI26KC

65

M

Rectum

I

wild type

MI35KC

72

F

Left colon

I

wild type

MI42KC

87

M

Right colon

I

wild type

MI43KC

67

M

Rectum

IV

mutated

MI38KC

59

F

Rectum

III

wild type

MI28KC

72

M

Rectum

IIA

wild type

MI14KC

59

F

Rectum

IIA

wild type

MI13KC

72

M

Right colon

IV

wild type

MI30KC

60

M

Right colon

I

wild type